With over 1,200 daily COVID deaths for many weeks, the U.S. is on track to reach a total of 1 million COVID-related deaths by the end of March. A shameful record for 2022.
To think that every week over 8,000 Americans are dying, mostly in hospital ICUs, is unbelievable – but that is no excuse for the lack of serious attention by the mainstream media. Take a moment to reflect that this is more deaths than those in the 9/11 attacks and Pearl Harbor, combined. And it is happening every week.
The late-stage problem
Hospitals have become killing machines, places where the kiss of death is a protocol following government guidelines. Despite wide COVID vaccine use, deaths in hospitals because of late-stage viral infection remain at a high level. Difficulty in getting COVID testing quickly and often probably contributes to the high death rate. Too many people do not get their COVID infection addressed early. There remains too little use of monoclonal antibodies early for infected people. So their infection progresses to serious lung and breathing problems. That is the beginning of the end.
And it will be a long time before the new antiviral drugs from Pfizer and Merck are broadly available, and there will be more information ascertained on whether or not they are really safe and effective for all diverse types of people.
In hospitals, patients with breathing problems and upper respiratory distress are giving medical actions that may address pain but inevitably lead to death, often after many weeks in the ICU. They typically get the useless and harmful drug remdesivir, supplemental oxygen, steroids and are intubated, put on a ventilator and usually put into a coma. Eventually, they die and become another COVID statistic.
It has been reported that the death rate for COVID patients prescribed remdesivir (26%) exceeds the fatality rate of COVID patients prescribed ivermectin, which is recorded by the Medicare database at 7.2%. And remdesivir has documented serious side effects.
In a few successful court actions, such late-stage COVID patients were given the cheap, safe generic ivermectin and – much to the astonishment of hospital doctors – have walked out of the hospital, completely recovered.
And there is considerable medical research literature supporting such use of ivermectin, principally because of its anti-inflammatory property. As just one example, a published medical 2021 hospital study found nearly a 50% reduction in deaths for patients with severe pulmonary involvement, the typical late-stage COVID death-bed patient condition. The many doubters of ivermectin should pay more attention to the medical science literature.
But published medical articles are ignored by the medical and public health establishments.
To be clear, a majority of hospitalized COVID patients have diabetes, are obese or have other serious underlying medical conditions. But though they get hospital attention, they do not all become late-stage COVID patients with deadly breathing and lung problems. Also, the omicron variant is known not to be like delta; it does not attack lungs in the same way. And delta is still active and deadly.
Hospitals stubbornly refuse to honor the few court decisions directing them to give death-bed late-stage COVID patients a chance of surviving by administering ivermectin. Hospitals use an army of lawyers and every dirty legal trick to overturn or delay those few court decisions that reach the sensible conclusion that there is nothing to lose by using ivermectin.
Indeed, here is the ugly truth: Hospital protocols for late-stage COVID patients have nearly a 100% record of failure. Their patients suffer and then die. Families desperate to get ivermectin used usually fail and watch their loved ones die.
This is a medical disgrace. This is the power of corporate medicine. This situation exemplifies the loss of medical freedom. This is the epitome of medical tyranny. This is a total loss of medical ethics. It is an extreme example of doctors failing to live up to their Hippocratic Oath. They follow hospital rules and let their patients die without trying what has a medical justification, without doing what other doctors have successfully done.
Apparently, that weekly death total is not enough to push hospitals and doctors to use what several nations have used to curb the COVID pandemic and save many millions of lives.
Hospital care arguments
Consider this paradox and hypocrisy. Virtually all hospitals put a priority on patient centered care. Patient-centered care focuses on the patient and the individual’s particular health care needs. The goal of patient-centered health care is to empower patients to become active participants in their care.
Clearly, denying patient and family pleas to use ivermectin with people facing death is totally inconsistent with this philosophy and hospital commitment.
Add to all this that demanding all patients use a one-size-fits-all medical treatment or hospital protocol is also counter to personalized medicine. Doctors need the freedom to use what suits their patient rather than what the government dictates or accepting what it withholds.
Court actions to get hospitals allowing ivermectin use might be more successful if both patient-centered care and personalized medicine arguments were presented to judges.
Time to let those who want to use ivermectin in an attempt to save their life get it. It is medically and morally the right thing to do.
With now a long record of hospital protocols for late-stage COVID utterly failing to save lives, how can the medical profession justify not using a generic medicine that both research and clinical results justify and explain its ability to save lives?
Families trying to find a lawyer and a friendly court face a very, very difficult race to save their loved one stuck in the ICU just like a prisoner sentenced to death.
Is it COVID killing these people or the medical profession and their hospital employers? Worth pondering as you keep watching mounting COVID death numbers.
Content created by the WND News Center is available for re-publication without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected].
This article was originally published by the WND News Center.